Blood Transfusion Diagnostics Market to Exceed US$ 7.7 Billion by 2034, Driven by Rising Blood Disorders and Demand for Safe Transfusion Practices | TMR

Blood Transfusion Diagnostics Market Overview

Blood transfusion diagnostics refers to a range of immunohematology tests and technologies used to ensure the safety, compatibility, and infection-free status of blood before transfusion. These diagnostics include screening methods such as ABO blood typing, Rh typing, antibody screening, and molecular disease testing, which are essential to prevent transfusion-related complications.

The market is witnessing steady growth due to the increasing demand for safe blood transfusions driven by rising prevalence of blood disorders, growing number of surgical procedures, and increasing incidence of road accidents. Additionally, the expanding geriatric population is contributing significantly to the demand for blood and related diagnostic procedures.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85892

The global blood transfusion diagnostics market was valued at US$ 4.6 Bn in 2023 and is projected to reach more than US$ 7.7 Bn by the end of 2034, expanding at a CAGR of 4.9% from 2024 to 2034. Market growth is driven by rising prevalence of blood disorders, increasing number of surgeries and trauma cases, and advancements in diagnostic technologies.

Analysis of Key Players in the Blood Transfusion Diagnostics Market

The global blood transfusion diagnostics market is fragmented, with several established and emerging players competing through innovation, product development, and strategic collaborations.

Key companies operating in the market include:

· Grifols, S.A.

· Werfen

· Ortho Clinical Diagnostics

· Abbott

· Bio-Rad Laboratories Inc.

· F. Hoffmann-La Roche Ltd.

· AliveDx

· BAG Diagnostics GmbH

· DiaSorin S.p.A.

· Prestige Diagnostics

· Atlas Medical

· Lorne Laboratories

These companies are focusing on developing advanced diagnostic solutions, expanding their global footprint, and strengthening partnerships with healthcare institutions to enhance product adoption.

Key Developments in Global Blood Transfusion Diagnostics Market

In April 2024, Grifols received CE mark for its new Procleix ArboPlex Assay, which is an automated nucleic acid test (NAT) for screening blood donors for detection of four major arboviruses including chikungunya, dengue, West Nile, and Zika viruses.

In November 2023, AliveDx announced that its state-of-the-art manufacturing facilities in Eysins, Switzerland and Edinburgh, United Kingdom have been granted In Vitro Diagnostic Regulation (IVDR) certification through EN ISO 13485:2016. The certification is a prerequisite for manufacturers of in-vitro diagnostics to continue their business in the European Union.

In June 2023, Werfen expanded its existing agreement with Seegene Inc. for the co-development of syndromic qPCR assays, suited to the Spanish and Portuguese healthcare systems. These assays include sexually transmitted infections and drug resistance.

Analysts' Viewpoint on the Global Blood Transfusion Diagnostics Market

Industry analysts highlight that the rising prevalence of blood disorders such as leukemia, thalassemia, sickle cell anemia, and hemophilia is a key factor driving market growth. The increasing need for safe and reliable blood transfusion processes is accelerating the adoption of advanced diagnostic solutions.

The emergence of automated systems and digital technologies has significantly improved donor management, data traceability, and workflow efficiency. Additionally, growing collaborations between healthcare providers and research institutions are contributing to innovation and expanding the application scope of blood transfusion diagnostics.

North America dominates the market due to advanced healthcare infrastructure and high adoption of innovative technologies, while Asia Pacific is expected to witness the fastest growth due to rising healthcare investments and increasing disease prevalence.

👉 Discuss Implications for Your Industry or Do you want customize Report, Please Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85892

Key Player Strategies

⚙️ Product Innovation

Development of advanced diagnostic assays and automated systems

🌐 Strategic Collaborations

Partnerships with research institutions and healthcare providers

🏥 Healthcare Integration

Expansion of diagnostic solutions in hospitals and blood banks

🔬 R&D Investments

Focus on molecular diagnostics and infection screening technologies

🌍 Global Expansion

Strengthening presence in emerging healthcare markets

Challenges

• High cost of advanced diagnostic instruments

• Stringent regulatory requirements for diagnostic approvals

• Limited access to advanced technologies in developing regions

• Risk of variability in testing procedures and outcomes

Opportunities

⚡ Rising Demand for Safe Blood Transfusion

Increasing awareness about transfusion safety and infection control

🏥 Growth in Healthcare Infrastructure

Expansion of blood banks and diagnostic centers

🔬 Technological Advancements

Adoption of automated and high-throughput diagnostic systems

🌱 Increasing Disease Screening

Growing focus on early detection and prevention of infections

🌍 Emerging Markets Expansion

Rising healthcare investments in Asia Pacific and other regions

Market Segmentation

By Product Type

• Instruments

• Kits & Reagents

By End-user

• Blood Banks

• Blood Donation/Transfusion Centers

• Others

By Application

• Blood Typing (ABO & Rh)

• Antibody Screening

• Disease Screening

• Cross-Matching

By Region

• North America – Leading region with advanced healthcare systems

• Europe – Strong regulatory framework and increasing awareness

• Asia Pacific – Fastest-growing region with rising demand

• Latin America

• Middle East & Africa

Regional Outlook

North America dominates the blood transfusion diagnostics market, supported by advanced healthcare infrastructure, high awareness levels, and strong financial investments in healthcare. The presence of leading market players and frequent product innovations further contribute to regional growth.

Europe is witnessing steady growth due to increasing prevalence of blood disorders and regulatory initiatives to ensure safe blood transfusion practices.

Asia Pacific is expected to grow at the fastest rate, driven by rising geriatric population, increasing healthcare expenditure, and growing adoption of advanced diagnostic technologies in countries such as China, India, and Japan.

Other regions, including Latin America and the Middle East & Africa, are gradually expanding due to improvements in healthcare infrastructure and increasing awareness regarding blood safety.

Why Invest in the Blood Transfusion Diagnostics Market Outlook 2034

✅ Steady market growth driven by increasing demand for safe blood transfusions

✅ Rising prevalence of blood disorders and chronic diseases

✅ Advancements in diagnostic technologies and automation

✅ Expanding healthcare infrastructure globally

✅ Growing opportunities in emerging markets

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=85892<ype=S

FAQs

1. What is the projected market size by 2034?

The market is expected to exceed US$ 7.7 Bn by 2034.

2. What is the CAGR of the market?

The market is projected to grow at a CAGR of 4.9% from 2024 to 2034.

3. What factors are driving market growth?

Rising blood disorders, increasing surgeries and accidents, and advancements in diagnostic technologies.

4. Which region dominates the market?

North America dominates due to advanced healthcare infrastructure and high adoption of diagnostics.

5. What are key trends in the market?

Automation in diagnostics, molecular testing advancements, and increasing focus on transfusion safety.

More Trending Reports by Transparency Market Research –

Forensic Technologies Market: https://www.transparencymarketresearch.com/forensics-technology.html

Regenerative Medicine Market: https://www.transparencymarketresearch.com/regenerative-medicines-market.html

Healthcare Biometrics Market: https://www.transparencymarketresearch.com/healthcare-biometrics-market.html

Multiplexed Diagnostics Market: https://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com